17 min

Neil Hayward, Ph.D. is CEO of eXIthera (eXIthera.com); eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation. Their drug candidates are small molecules that prevent thrombosis without an increased risk in bleeding. ForbesBooks Radio

    • Business

ForbesBooks.com

ForbesBooks.com

17 min

Top Podcasts In Business